JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farah, A.
Right arrow Articles by Maresh, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Farah, A.
Right arrow Articles by Maresh, G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 92, Issue 1, 32-42, 1948
Copyright © 1948 by American Society for Pharmacology and Experimental Therapeutics


DETERMINATION OF THE THERAPEUTIC, IRREGULARITY, AND LETHAL DOSES OF CARDIAC GLYCOSIDES IN THE HEART-LUNG PREPARATION OF THE DOG

Alfred Farah 1 and George Maresh 1

1 Department of Pharmacology, Harvard Medical School, Boston, Massachusetts

The influence of rate of administration on the therapeutic, irregularity, and lethal dose of the glycosides digitoxin, g-strophanthin, digoxin, oleandrin, and lanatoside B has been studied in the HLP of the dog. A reduction of the rate of administration results in a reduction of all these values until the optimal rate of administration is reached. At and below the optimal rate of administration, the minimal therapeutic dose, minimal irregularity dose, and minimal lethal dose are determined. On a molar basis the cardiac glycosides studied have the following order of decreasing potency: g-strophanthin, digoxin, digitoxin, oleandrin, and lanatoside B.

The average ratios of irregularity dose to therapeutic dose and lethal dose to therapeutic dose are the same for all the five glycosides studied. The therapeutic dose is about 15 per cent and the irregularity dose is approximately 60 per cent of the lethal dose.

The authors wish to thank Dr. Otto Krayer for help and advice in the course of this investigation, and Mr. Henry George and Louis Harris for valuable technical assistance.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1948 by the American Society for Pharmacology and Experimental Therapeutics.